Researchers in China may have uncovered a surprising ally in the fight against sugar cravings and metabolic disorders: a ...
Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making ...
Hormones can be helpful heroes, supporting the immune system and a healthy sleep-wake schedule. But they can also be culprits ...
Glucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents-have been ...
An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...
When we think about the immune system, we usually associate it with fighting infections. However, a study published in Science by the Champalimaud Foundation reveals a surprising new role.
Findings suggest targeting neuro-immune pathway could lead to strategies for managing diabetes, obesity or some types of ...
New study shows that the gene G6PC2 plays an important role in regulating glucagon, a hormone that raises blood sugar levels.
Scientists have found a way to help the body make more of an Ozempic-like fullness hormone to cut cravings and improve health.
The study proposes the immune system as a major regulator of blood sugar. The functions of hormones like insulin and glucagon ...
With the holidays past and the new year arrived, we look ahead — to losing weight. For some that resolve theoretically ...
Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have been ...